Figure 2.
Possible causes for uncoupling bone turnover in thalassemic patients
IGF-1: insulin-like growth factor-1, RANKL/OPG: receptor activator of nuclear factor kappa-ß/osteoprotegerin
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.